Arighi E - Search Results

1

Vascular endothelial growth factor receptor-3.

Taipale J, Makinen T, Arighi E, Kukk E, Karkkainen M, Alitalo K. Taipale J, et al. Among authors: arighi e. Curr Top Microbiol Immunol. 1999;237:85-96. doi: 10.1007/978-3-642-59953-8_5. Curr Top Microbiol Immunol. 1999. PMID: 9893347 Review. No abstract available.

2

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.

Joukov V, Kumar V, Sorsa T, Arighi E, Weich H, Saksela O, Alitalo K. Joukov V, et al. Among authors: arighi e. J Biol Chem. 1998 Mar 20;273(12):6599-602. doi: 10.1074/jbc.273.12.6599. J Biol Chem. 1998. PMID: 9506953 Free article.

3

Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium.

Rajantie I, Ekman N, Iljin K, Arighi E, Gunji Y, Kaukonen J, Palotie A, Dewerchin M, Carmeliet P, Alitalo K. Rajantie I, et al. Among authors: arighi e. Mol Cell Biol. 2001 Jul;21(14):4647-55. doi: 10.1128/MCB.21.14.4647-4655.2001. Mol Cell Biol. 2001. PMID: 11416142 Free PMC article.

4

Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation.

Klefstrom J, Arighi E, Littlewood T, Jäättelä M, Saksela E, Evan GI, Alitalo K. Klefstrom J, et al. Among authors: arighi e. EMBO J. 1997 Dec 15;16(24):7382-92. doi: 10.1093/emboj/16.24.7382. EMBO J. 1997. PMID: 9405367 Free PMC article.

5

The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner.

Ekman N, Arighi E, Rajantie I, Saharinen P, Ristimäki A, Silvennoinen O, Alitalo K. Ekman N, et al. Among authors: arighi e. Oncogene. 2000 Aug 24;19(36):4151-8. doi: 10.1038/sj.onc.1203763. Oncogene. 2000. PMID: 10962576

6

GDNF promotes tubulogenesis of GFRalpha1-expressing MDCK cells by Src-mediated phosphorylation of Met receptor tyrosine kinase.

Popsueva A, Poteryaev D, Arighi E, Meng X, Angers-Loustau A, Kaplan D, Saarma M, Sariola H. Popsueva A, et al. Among authors: arighi e. J Cell Biol. 2003 Apr 14;161(1):119-29. doi: 10.1083/jcb.200212174. Epub 2003 Apr 7. J Cell Biol. 2003. PMID: 12682085 Free PMC article.

7

RET tyrosine kinase signaling in development and cancer.

Arighi E, Borrello MG, Sariola H. Arighi E, et al. Cytokine Growth Factor Rev. 2005 Aug-Oct;16(4-5):441-67. doi: 10.1016/j.cytogfr.2005.05.010. Cytokine Growth Factor Rev. 2005. PMID: 15982921 Review.

8

Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.

Arighi E, Popsueva A, Degl'Innocenti D, Borrello MG, Carniti C, Perälä NM, Pierotti MA, Sariola H. Arighi E, et al. Mol Endocrinol. 2004 Apr;18(4):1004-17. doi: 10.1210/me.2003-0173. Epub 2004 Jan 8. Mol Endocrinol. 2004. PMID: 14715928

9

Identification of Shc docking site on Ret tyrosine kinase.

Arighi E, Alberti L, Torriti F, Ghizzoni S, Rizzetti MG, Pelicci G, Pasini B, Bongarzone I, Piutti C, Pierotti MA, Borrello MG. Arighi E, et al. Oncogene. 1997 Feb 20;14(7):773-82. doi: 10.1038/sj.onc.1200896. Oncogene. 1997. PMID: 9047384

10

Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.

Mercalli E, Ghizzoni S, Arighi E, Alberti L, Sangregorio R, Radice MT, Gishizky ML, Pierotti MA, Borrello MG. Mercalli E, et al. Among authors: arighi e. Oncogene. 2001 Jun 14;20(27):3475-85. doi: 10.1038/sj.onc.1204462. Oncogene. 2001. PMID: 11429694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters